搜尋
Faeth Therapeutics Ord Shs
FTH添加自選
10.540USD
-11.510-52.20%
交易中 11/09, 12:16（美東）
272.35M總市值
0.00本益比TTM
關於 Faeth Therapeutics Ord Shs 公司
Faeth Therapeutics, Inc., formerly Sensei Biotherapeutics, Inc., is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The Company's lead program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer. PIKTOR engages three nodes simultaneously: PI3K-alpha upstream, mTORC1 and mTORC2 downstream, simultaneously. PIKTOR is designed to deliver multi-node pathway inhibition in an oral formulation. Its pipelines include PIKTOR (PIK-201), PIKTOR (PIK-101) and Sapanisertib.
Faeth Therapeutics Ord Shs 簡介
公司代碼- -
公司名稱- -
上市日期- -
CEO- -
員工數量- -
證券類型- -
年結日- -
公司地址- -
城市- -
上市交易所- -
國家- -
郵編- -
電話- -
網址- -
公司代碼- -
上市日期- -
CEO- -
Faeth Therapeutics Ord Shs公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Stephen M. Hahn, M.D.
Mr. Stephen M. Hahn, M.D.
Director
Director
44.76K
--
Mr. Stephen M. Hahn, M.D.
Mr. Stephen M. Hahn, M.D.
Director
Director
44.76K
--
Mr. Bob Holmen
Mr. Bob Holmen
Independent Director
Independent Director
1.28K
-0.08%
Mr. Bob Holmen
Mr. Bob Holmen
Independent Director
Independent Director
1.28K
-0.08%
Mr. Josiah Craver
Mr. Josiah Craver
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
--
--
Mr. Christopher W. Gerry
Mr. Christopher W. Gerry
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
Mr. Phillip B. Donenberg
Mr. Phillip B. Donenberg
Independent Director
Independent Director
--
--
Mr. Anand K. Parikh, J.D.
Mr. Anand K. Parikh, J.D.
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
--
--
Ms. Saira Ramasastry
Ms. Saira Ramasastry
Director
Director
--
--
Dr. Karen Vousden, Ph.D.
Dr. Karen Vousden, Ph.D.
Director
Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Stephen M. Hahn, M.D.
Mr. Stephen M. Hahn, M.D.
Director
Director
44.76K
--
Mr. Stephen M. Hahn, M.D.
Mr. Stephen M. Hahn, M.D.
Director
Director
44.76K
--
Mr. Bob Holmen
Mr. Bob Holmen
Independent Director
Independent Director
1.28K
-0.08%
Mr. Bob Holmen
Mr. Bob Holmen
Independent Director
Independent Director
1.28K
-0.08%
Mr. Josiah Craver
Mr. Josiah Craver
Senior Vice President - Finance, Principal Accounting Officer
Senior Vice President - Finance, Principal Accounting Officer
--
--
Mr. Christopher W. Gerry
Mr. Christopher W. Gerry
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
--
--
常見問題
Faeth Therapeutics Ord Shs的前五大股東是誰？
Faeth Therapeutics Ord Shs的前五大股東如下：Mr. Stephen M. Hahn, M.D.